Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-06-30 Tax Withholding |
2021-07-02 4:04 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Crotty Robert Gen Counsel & Corp Secretary |
37 | $1.35 | 41,416 (Direct) |
View |
| 2021-06-06 Tax Withholding |
2021-06-08 4:10 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Schroeder Theodore R Chief Executive Officer |
225 | $1.34 | 177,871 (Direct) |
View |
| 2021-06-06 Tax Withholding |
2021-06-08 4:09 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Gelone Steven P. President and COO |
92 | $1.34 | 367,127 (Direct) |
View |
| 2021-06-06 Tax Withholding |
2021-06-08 4:05 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Crotty Robert Gen Counsel & Corp Secretary |
73 | $1.34 | 41,453 (Direct) |
View |
| 2021-06-02 Option Award |
2021-06-04 5:51 pm |
N/A 2031-06-01 |
Nabriva Therapeutics plc | NBRV | Dalton Lisa Director |
10,500 | $0 | 10,500 (Direct) |
View |
| 2021-06-02 Option Award |
2021-06-04 5:50 pm |
N/A 2031-06-01 |
Nabriva Therapeutics plc | NBRV | CORRIGAN MARK Director |
10,500 | $0 | 10,500 (Direct) |
View |
| 2021-05-31 Tax Withholding |
2021-06-02 4:12 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Schroeder Theodore R Chief Executive Officer |
107 | $1.38 | 178,096 (Direct) |
View |
| 2021-05-31 Tax Withholding |
2021-06-02 4:11 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Crotty Robert Gen Counsel & Corp Secretary |
37 | $1.38 | 41,526 (Direct) |
View |
| 2021-05-31 Tax Withholding |
2021-06-02 4:10 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Gelone Steven P. President and COO |
63 | $1.38 | 367,219 (Direct) |
View |
| 2021-05-06 Tax Withholding |
2021-05-10 5:53 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Schroeder Theodore R Chief Executive Officer |
225 | $1.49 | 178,203 (Direct) |
View |
| 2021-05-06 Tax Withholding |
2021-05-10 5:52 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Gelone Steven P. President and COO |
92 | $1.49 | 367,282 (Direct) |
View |
| 2021-05-06 Tax Withholding |
2021-05-10 5:51 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Crotty Robert Gen Counsel & Corp Secretary |
74 | $1.49 | 41,563 (Direct) |
View |
| 2021-04-30 Tax Withholding |
2021-05-04 4:04 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Crotty Robert Gen Counsel & Corp Secretary |
37 | $1.78 | 41,637 (Direct) |
View |
| 2021-04-30 Tax Withholding |
2021-05-04 4:04 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Gelone Steven P. President and COO |
63 | $1.78 | 367,374 (Direct) |
View |
| 2021-04-30 Tax Withholding |
2021-05-04 4:03 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Schroeder Theodore R Chief Executive Officer |
107 | $1.78 | 178,428 (Direct) |
View |
| 2021-04-28 Option Award |
2021-04-30 4:47 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Gelone Steven P. President and COO |
290,697 | $0 | 367,437 (Direct) |
View |
| 2021-04-06 Tax Withholding |
2021-04-08 9:48 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Schroeder Theodore R Chief Executive Officer |
225 | $1.73 | 178,535 (Direct) |
View |
| 2021-03-06 Tax Withholding |
2021-04-08 9:48 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Schroeder Theodore R Chief Executive Officer |
225 | $1.79 | 178,535 (Direct) |
View |
| 2021-02-06 Tax Withholding |
2021-04-08 9:48 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Schroeder Theodore R Chief Executive Officer |
2,695 | $2.9 | 178,535 (Direct) |
View |
| 2021-04-06 Tax Withholding |
2021-04-08 9:47 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Gelone Steven P. President and COO |
92 | $1.73 | 76,740 (Direct) |
View |
| 2021-03-06 Tax Withholding |
2021-04-08 9:47 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Gelone Steven P. President and COO |
92 | $1.79 | 76,740 (Direct) |
View |
| 2021-02-06 Tax Withholding |
2021-04-08 9:47 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Gelone Steven P. President and COO |
1,104 | $2.9 | 76,740 (Direct) |
View |
| 2021-04-06 Tax Withholding |
2021-04-08 9:46 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Crotty Robert Gen Counsel & Corp Secretary |
74 | $1.73 | 41,674 (Direct) |
View |
| 2021-03-06 Tax Withholding |
2021-04-08 9:46 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Crotty Robert Gen Counsel & Corp Secretary |
71 | $1.79 | 41,674 (Direct) |
View |
| 2021-02-06 Tax Withholding |
2021-04-08 9:46 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Crotty Robert Gen Counsel & Corp Secretary |
870 | $2.9 | 41,674 (Direct) |
View |
| 2021-03-31 Tax Withholding |
2021-04-02 6:14 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Gelone Steven P. President and COO |
63 | $1.66 | 78,028 (Direct) |
View |
| 2021-03-31 Tax Withholding |
2021-04-02 6:12 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Crotty Robert Gen Counsel & Corp Secretary |
37 | $1.66 | 42,689 (Direct) |
View |
| 2021-03-31 Tax Withholding |
2021-04-02 6:11 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Schroeder Theodore R Chief Executive Officer |
107 | $1.66 | 181,680 (Direct) |
View |
| 2021-03-31 Option Award |
2021-04-02 6:09 pm |
N/A 2031-03-30 |
Nabriva Therapeutics plc | NBRV | Dolan Daniel Chief Financial Officer |
100,000 | $0 | 100,000 (Direct) |
View |
| 2021-02-28 Tax Withholding |
2021-03-02 7:43 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Sender Gary Chief Financial Officer |
31 | $2.39 | 20,472 (Direct) |
View |
| 2021-02-28 Tax Withholding |
2021-03-02 7:42 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Schroeder Theodore R Chief Executive Officer |
106 | $2.39 | 181,787 (Direct) |
View |
| 2021-02-28 Tax Withholding |
2021-03-02 7:40 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Schranz Jennifer Chief Medical Officer |
33 | $2.39 | 39,125 (Direct) |
View |
| 2021-02-28 Tax Withholding |
2021-03-02 7:39 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Gelone Steven P. President and COO |
63 | $2.39 | 78,091 (Direct) |
View |
| 2021-02-28 Tax Withholding |
2021-03-02 7:37 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Crotty Robert Gen Counsel & Corp Secretary |
38 | $2.39 | 42,726 (Direct) |
View |
| 2021-01-29 Option Award |
2021-02-02 8:06 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Crotty Robert Gen Counsel & Corp Secretary |
22,500 | $0 | 42,764 (Direct) |
View |
| 2021-01-31 Tax Withholding |
2021-02-02 8:06 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Crotty Robert Gen Counsel & Corp Secretary |
43 | $2.62 | 42,764 (Direct) |
View |
| 2021-01-31 Tax Withholding |
2021-02-02 8:01 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Sender Gary Chief Financial Officer |
37 | $2.62 | 20,503 (Direct) |
View |
| 2021-01-29 Option Award |
2021-02-02 8:01 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Schroeder Theodore R Chief Executive Officer |
117,500 | $0 | 181,893 (Direct) |
View |
| 2021-01-31 Tax Withholding |
2021-02-02 8:01 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Schroeder Theodore R Chief Executive Officer |
125 | $2.62 | 181,893 (Direct) |
View |
| 2021-01-29 Option Award |
2021-02-02 8:00 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Schranz Jennifer Chief Medical Officer |
22,500 | $0 | 39,158 (Direct) |
View |
| 2021-01-31 Tax Withholding |
2021-02-02 8:00 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Schranz Jennifer Chief Medical Officer |
36 | $2.62 | 39,158 (Direct) |
View |
| 2021-01-29 Option Award |
2021-02-02 7:57 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Gelone Steven P. President and COO |
42,500 | $0 | 78,154 (Direct) |
View |
| 2021-01-31 Tax Withholding |
2021-02-02 7:57 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Gelone Steven P. President and COO |
75 | $2.62 | 78,154 (Direct) |
View |
| 2020-12-31 Tax Withholding |
2021-01-05 5:16 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Sender Gary Chief Financial Officer |
32 | $2.42 | 20,540 (Direct) |
View |
| 2020-12-31 Tax Withholding |
2021-01-05 5:15 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Schroeder Theodore R Chief Executive Officer |
121 | $2.42 | 64,518 (Direct) |
View |
| 2020-12-31 Tax Withholding |
2021-01-05 5:14 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Schranz Jennifer Chief Medical Officer |
30 | $2.42 | 16,694 (Direct) |
View |
| 2020-12-31 Tax Withholding |
2021-01-05 5:13 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Gelone Steven P. President and COO |
63 | $2.42 | 35,729 (Direct) |
View |